| Jeremy Louis Pascotto, DO, | |
|
123 Lansing St, Suite 2, Charlotte, MI 48813-1696 | |
| (517) 543-7976 | |
| Not Available |
| Full Name | Jeremy Louis Pascotto |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 15 Years |
| Location | 123 Lansing St, Charlotte, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548498140 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 5101018201 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sparrow Home Care | Lansing, MI | Home health agency |
| Great Lakes Caring | Jackson, MI | Home health agency |
| Sparrow Eaton Hospital | Charlotte, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sparrow Eaton Hospital | 0042103509 | 32 |
News Archive
Health officials attending last week's World Health Assembly "failed to come to an agreement on a binding convention on stimulating research and development [R&D] focusing on the health problems of developing countries," BMJ reports.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.
EKF Diagnostics, the global in vitro diagnostics company, announces it has secured new contracts for the manufacture and supply of a novel, patented sample collection device which allows COVID-19 samples to be rapidly inactivated in the collection tube, avoiding contamination and preserving RNA without need for refrigeration.
Three surgeons will showcase implant technology from global engineering and healthcare technologies company, Renishaw, during a masterclass at the British Association of Oral and Maxillofacial Surgeons conference this year.
UCSF has received a $1.15 million grant from the Bill & Melinda Gates Foundation to determine if integrating family planning into HIV treatment and care will increase contraceptive use and decrease unintended pregnancy among HIV-positive women. UCSF will partner with the Kenya Medical Research Institute and Ibis Reproductive Health to conduct the research.
› Verified 8 days ago
| Entity Name | Sparrow Eaton Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043419427 PECOS PAC ID: 0042103509 Enrollment ID: O20040213000368 |
News Archive
Health officials attending last week's World Health Assembly "failed to come to an agreement on a binding convention on stimulating research and development [R&D] focusing on the health problems of developing countries," BMJ reports.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.
EKF Diagnostics, the global in vitro diagnostics company, announces it has secured new contracts for the manufacture and supply of a novel, patented sample collection device which allows COVID-19 samples to be rapidly inactivated in the collection tube, avoiding contamination and preserving RNA without need for refrigeration.
Three surgeons will showcase implant technology from global engineering and healthcare technologies company, Renishaw, during a masterclass at the British Association of Oral and Maxillofacial Surgeons conference this year.
UCSF has received a $1.15 million grant from the Bill & Melinda Gates Foundation to determine if integrating family planning into HIV treatment and care will increase contraceptive use and decrease unintended pregnancy among HIV-positive women. UCSF will partner with the Kenya Medical Research Institute and Ibis Reproductive Health to conduct the research.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeremy Louis Pascotto, DO, 123 Lansing St, Suite 2, Charlotte, MI 48813-1696 Ph: (517) 543-7976 | Jeremy Louis Pascotto, DO, 123 Lansing St, Suite 2, Charlotte, MI 48813-1696 Ph: (517) 543-7976 |
News Archive
Health officials attending last week's World Health Assembly "failed to come to an agreement on a binding convention on stimulating research and development [R&D] focusing on the health problems of developing countries," BMJ reports.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.
EKF Diagnostics, the global in vitro diagnostics company, announces it has secured new contracts for the manufacture and supply of a novel, patented sample collection device which allows COVID-19 samples to be rapidly inactivated in the collection tube, avoiding contamination and preserving RNA without need for refrigeration.
Three surgeons will showcase implant technology from global engineering and healthcare technologies company, Renishaw, during a masterclass at the British Association of Oral and Maxillofacial Surgeons conference this year.
UCSF has received a $1.15 million grant from the Bill & Melinda Gates Foundation to determine if integrating family planning into HIV treatment and care will increase contraceptive use and decrease unintended pregnancy among HIV-positive women. UCSF will partner with the Kenya Medical Research Institute and Ibis Reproductive Health to conduct the research.
› Verified 8 days ago
Arjuna James Cuddeback, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 616 Meijer Dr Ste 101, Charlotte, MI 48813 Phone: 517-543-7976 | |
John M Thiel, DO Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 123 Lansing St, Suite 2, Charlotte, MI 48813 Phone: 517-543-7976 |